In clinical human cytomegalovirus (HCMV) infections, virus infected granulocytes and monocytes have been implicated in the dissemination of virus through the body. In vitro, human neutrophilic granulocytes and monocytes have been shown to acquire and transfer infectious virus to uninfected cells. The aim of this study was to determine the role of leukocytes in the dissemination of cytomegalovirus in vivo. From 3 days after intraperitoneal injection with cell-free rat CMV (RCMV), RCMV-DNA was detectable in whole blood samples. Moreover, replicating virus could be cultured from leukocytes isolated from these blood samples, indicating that during active infection rats experience a viremia that is comparable to humans with an active HCMV infection. Rat cytomegalovirus (RCMV) could be transferred to rat granulocytes and monocytes by cocultivation with RCMV-infected rat embryonic fibroblasts. In vitro, these phagocytes were able to transfer RCMV to uninfected rat fibroblasts. Electron microscopy and PCR confirmed the presence of virus particles and viral DNA in both granulocytes and monocytes. Subsequently, intravenous injection of purified infected granulocytes or monocytes into irradiated rats resulted in a systemic infection. Infection of the animals proved to be efficient, since virus replication could be demonstrated in spleen and salivary glands already after a single low dose injection of infected phagocytes.
ABSTRACT
In clinical human cytomegalovirus (HCMV) infections, virus infected granulocytes and monocytes have been implicated in the dissemination of virus through the body. In vitro, human neutrophilic granulocytes and monocytes have been shown to acquire and transfer infectious virus to uninfected cells. The aim of this study was to determine the role of leukocytes in the dissemination of cytomegalovirus in vivo. From 3 days after intraperitoneal injection with cell-free rat CMV (RCMV), RCMV-DNA was detectable in whole blood samples. Moreover, replicating virus could be cultured from leukocytes isolated from these blood samples, indicating that during active infection rats experience a viremia that is comparable to humans with an active HCMV infection. Rat cytomegalovirus (RCMV) could be transferred to rat granulocytes and monocytes by cocultivation with RCMV-infected rat embryonic fibroblasts. In vitro, these phagocytes were able to transfer RCMV to uninfected rat fibroblasts. Electron microscopy and PCR confirmed the presence of virus particles and viral DNA in both granulocytes and monocytes. Subsequently, intravenous injection of purified infected granulocytes or monocytes into irradiated rats resulted in a systemic infection. Infection of the animals proved to be efficient, since virus replication could be demonstrated in spleen and salivary glands already after a single low dose injection of infected phagocytes.
We show for the first time in vivo that cytomegalovirus is able to disseminate through infected leukocytes. Based on the in vitro data on transmission of HCMV, we hypothesise that our model is a powerful tool to gain further insight on CMV dissemination and for the development of new antiviral agents.
INTRODUCTION
Human Cytomegalovirus (HCMV) is a member of the herpes virus family. Primary infections or reactivations of this virus in the immunocompromised host, such as transplant recipients and AIDS patients, cause severe morbidity and mortality 20, 28, 29 . Like other herpes viruses, HCMV can establish a latent and persistent infection. Although for HCMV the site of latency has not been fully established, bone marrow progenitor cells, monocytes and vascular endothelial cells are thought to be a reservoir of latent virus 7, 15, 17, 18, 23 . During acute infection or reactivation, presence of HCMV-antigens can be demonstrated in monocytes and polymorphonuclear cells (PMNs) using the antigenemia assay. In this assay, the presence of the viral matrix protein pp65 (ppUL83) can be demonstrated in the nucleus of infected leukocytes 11, 12, 26 . During active infection, PMNs are abortively infected. In these cells, transcription of the HMCV genome is blocked after expression of the Immediate Early (IE) genes IE1 and IE2 9, 11 .
It is hypothesised that HCMV uses monocytes and PMNs as a vehicle for dissemination through the body. Evidence for this hypothesis was derived from in vitro studies in which it was shown that PMNs can take up virus after cocultivation with endothelial cells that were infected with clinical isolates of HCMV 10, 13, 14, 21 . The presence of intact viral particles in these leukocytes could also be demonstrated with electron microscopy 10, 14, 21 . Furthermore, infected PMNs were able to transfer the virus to uninfected cells after cocultivation. Monocytes could also acquire HCMV from infected endothelium and subsequently transfer the virus to uninfected cells in vitro 27 .
From the currently used animal models for CMV infection, little is known about the mechanism of dissemination of the virus. In a murine model for CMV infections (MCMV) viral DNA was detected in mononuclear leukocytes in blood of infected mice 1, 25 .
We investigated whether rat cytomegalovirus (RCMV) could be transferred from RCMV-infected cells to granulocytes and monocytes in vitro, similar to the in vitro transmission studies with HCMV. Furthermore, we studied whether RCMV-infected leukocytes could cause an active RCMV infection after intravenous administration in vivo. This would represent an animal model for clinical dissemination of HCMV.
MATERIALS & METHODS

Production of virus.
RCMV stocks were produced as described earlier 5 . In brief, male SPF F344 rats (Harlan, Zeist, The Netherlands), 8 weeks of age, received 5 Gy total body irradiation (TBI) and were subsequently infected with the Maastricht strain RCMV. Animals were held at the Central Animal Facility of the University of Groningen and received standard food and water ad libitum. Four weeks after infection, rats were sacrificed and the submandibular glands were removed. The salivary glands were homogenized and centrifuged as described and virus stocks were stored at -80°C until tested in a plaque assay to quantify the amount of virus in the homogenate.
Infection of rat lung fibroblasts.
The rat lung fibroblast cell line RFL-6 (ECACC, UK) was cultured in 162 cm 2 culture flasks plates (Corning Costar, Cambridge, UK), using DMEM/HAM F12 (Biowhittaker Europe, Verviers, Belgium), supplemented with 20% Fetal Calf Serum (FCS) (Brunschwig Chemie, Maarssen, The Netherlands), 200 mM Lglutamin (Gibco BRL, Paisley, Scotland), 60 µg/ml gentamycine sulphate (Gibco BRL, Paisley, Scotland) and 1% Non Essential Amino Acids (Gibco BRL, Paisley, Scotland) at 37°C and 5% CO 2 . Prior to infection, cells were seeded in 6-wells plates (Corning Costar) and were serum starved in two steps, until maintained on culture medium with 5% FCS. Subsequently, RCMV was added at a multiplicity of infection (MOI) of 1.0.
Detection of virus in leukocytes of infected rats.
Male PVG rats (n= 6, Harlan), 4 weeks of age, received 5 Gy TBI and were subsequently injected intraperitoneally with 1 x 10 6 pfu free virus, 16 h. after TBI. At several time points after infection, animals were anaesthetised and heparinised blood samples (400 µl) were obtained by orbital punctures. Subsequently, 200 µl of the blood samples was used to isolate mononuclear and granulocyte fractions as described. The isolated cell fractions were cocultivated with uninfected RFL-6 fibroblasts and checked for virus transmission. The other 200 µl of the blood samples was stored in lysisbuffer, containing 6 M guanidin isothiocyanate. DNA was isolated and a nested PCR was performed to detect RCMV DNA in the isolated leukocyte fractions.
Generation of RCMV-infected PMNs and monocytes.
Male PVG rats (Harlan), 8 weeks of age, were anaesthetised and a maximal amount of blood was obtained with a heart puncture. Subsequently, the animals were terminated. Blood was collected in heparinised tubes, mixed in equal volumes with Phosphate Buffered Saline (PBS) and loaded on lymfolyte Rat (Cedarlane Laboratories, Ontario, Canada). Cells were centrifuged at 2,500 rpm for 30 min. The mononuclear cell fraction and the cell pellet, containing erythrocytes and PMNs, was retrieved and kept on ice. Contaminating erythrocytes were removed by lysis with a hypotonic buffer, consisting of 155 mM NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM Na 2 EDTA.
The granulocyte and monocyte cell fractions were washed and cocultivated with infected RFL-6 cells at 37°C, 5% CO 2 and 100% relative humidity for 2 h. The leukocytes were removed from the infected fibroblast layer by gentle aspiration and transferred to empty trans-well plates (Corning Costar, Cambridge, UK). The PMNs and monocytes were allowed to migrate for 16 h against a chemotactic gradient of 0.4 µM fMLP (Sigma, St. Louis, MO), or 1.0 µM of histamin (Sigma) respectively. The transmigrated leukocytes were washed twice with saline, assessed for viability in trypan blue and stored on ice until further use.
As a negative control, to correct for cell free virus present in the culture medium, infected fibroblasts were incubated on a trans-well plate with 0.4 µM fMLP or 1.0 µM histamin as chemoattractant. The fibroblasts failed to migrate, however infectious cell free virus was detected in the lower chamber of the transwell plate. Therefore, transmigrated cell fractions were washed twice with PBS to remove free virus particles before further use.
Electron Microscopy studies.
PMNs and monocytes were isolated as described and were subsequently cocultivated with infected RFL-6 fibroblasts in 6-wells plates (Corning Costar, Cambridge, UK) at 37°, 5% CO 2 and 100% relative humidity for 12 h. Cells were fixed with 2% glutaraldehyde in PBS and embedded in epon. Ultrathin sections (80 nm) were prepared and stained with uranyl acetate and lead acetate. Sections were evaluated in a 201 Philips transmission electron microscope (Philips, Eindhoven, The Netherlands).
Detection of RCMV DNA by PCR.
Purified leukocytes, or whole blood samples were stored in lysis buffer, containing 6 M guanidin isothiocyanate and kept at -80° until further use. DNA was isolated from these samples according to standard procedures and a nested PCR was performed as described 2 . Primers, directed against the RCMV UL54
DNA polymerase gene, were used (GenBank accession number: U50550) to amplify a product of 431 bp. The obtained DNA products were analysed by agarose gel electrophoresis followed by staining with ethidium bromide.
Infection of rats with PMNs or monocytes.
Male PVG rats (Harlan) received 5 Gy TBI and were injected in the tail vene with RCMV-infected neutrophilic granulocytes or monocytes at 16 h after irradiation. All animals were sacrificed at 4 weeks post infection (p.i.). Sera were obtained by heart puncture. Subsequently, submandibular salivary glands and spleen were removed and homogenized for determination of the virus titers using a plaque assay, and for histology. Furthermore, the pancreas, hart, lung, liver, colon and kidney were removed for histological evaluation.
Histochemical evaluation.
Organs were fixed in 3.7% formalin solution in PBS for 24 h., and subsequently embedded in paraffin, according to standard methods. Sections of 4µm were prepared and stained with hematoxillin and eosin. In order to assess the presence of viral antigens, sections were incubated with murine monoclonal antibody 8 or 35 according to standard indirect immunohistochemical procedures 16 .
Quantification of virus titres using plaque assay.
The amount of virus present in salivary gland and spleen homogenates was quantified using a plaque assay 4 . In brief, Rat Embryonal Fibroblasts (REF) were produced and cultured using standard methods 24 . Tenfold serial dilutions of tissue homogenates were added to the confluent layers of REFs and incubated for 1 h at 37°C, 5% CO 2 and 100% relative humidity. The tissue homogenates were removed and replaced by culture medium, supplemented with 1% hydroxypropyl methyl cellulosum (Brocacef, Maarssen, The Netherlands). Plates were cultured at 37°C, 5% CO 2 and 100% relative humidity for 7 days, followed by fixation with 3.7% formalin in PBS. Cells were stained with methylene blue and the number of virus plaques was microscopically evaluated. The virus titre was expressed as the number of plaque forming units (pfu) per gram tissue.
To determine the number of infected PMNs after cocultivation and transmigration, 10,000 PMNs per well were added to confluent layer of REFs in a 6-wells plate. The cells were fixated with culture medium, supplemented with 1% methyl cellulosum. Plates were cultured at 37°C, 5% CO 2 and 100% relative humidity for 7 days. Fixation and staining was performed as described and the number of plaques was counted.
RESULTS
Detection of virus in leukocytes of RCMV infected rats.
Using a nested PCR, we were able to demonstrate the presence of RCMV DNA in whole blood of rats that were intraperitoneally infected with cell free virus (Fig. 1) . At day 1 after infection, all samples were RCMV-DNA negative, meaning that input of virus was below detection level. However, starting from day 3, RCMV DNA was isolated from whole blood, indicating that viral replication had taken place. At 7 days p.i., RMCV DNA was detectable in a number of blood samples already after the first round of amplification, indicating a relatively high viral load. Moreover, the presence of virus DNA could be demonstrated in blood samples up to over 60 days post infection, after the second amplification round. At certain time points, blood samples were also RCMV DNA-negative. This can partially be ascribed to the little amounts of blood (<200µl) that were obtained after orbital puncture. In addition, at 7 and 21 days p.i. we were able to culture RCMV from both PMNs and mononuclear cell fractions, obtained from blood samples of the rats infected with cell free virus (Fig.2) . These results indicate a viremia that is comparable to clinical HCMV infections.
Fig. 1: Presence of RCMV DNA in whole blood samples of rats infected with cell free RCMV.
A.Viral DNA, amplified by nested PCR, after loading on an agarose gel and staining with ethidium bromide. Lane 1: 100bp marker, Lane 2: negative control (H2O), Lane 3-13: Timecourse of blood samples obtained at day 1, 2, 4, 7, 18, 21, 25, 28, 32, 42, 46, 49, 53, 56, 30, and 63, respectively. The blood samples were RCMV-negative at day 7 and 56 after infection. As a control, GAPDH DNA was amplified for every sample (B).
Generation of RCMV-infected PMNs and monocytes.
PMNs or monocytes, after a 2-hour cocultivation period with infected RFL-6 fibroblasts, were transferred to uninfected fibroblasts, incubated for another 2 h and subsequently removed. After approximately 2 days, the fibroblasts showed cytopathic effect (cpe), and after approximately 5 days plaques had formed. Immunohistochemical staining with Mab 8 or Mab 35 proved that the fibroblasts were infected with RCMV similar to PMNs and MNCs isolated form blood (Fig  2) .
It proved to be essential that leukocyte populations were purified by transmigration, since staining for α-actin of the leukocyte fractions without transmigration protocol showed contamination with detached, infected-, α-actinpositive fibroblasts. Although the contaminating fibroblasts represented only 0.5% of the total cell population, cocultivation in vitro, or i.v. injection of this low amount of infected fibroblasts into rats also resulted in a viral infection (data not shown). After transmigration, contamination of the leukocyte populations with fibroblasts could be excluded as judged by the negative α-actin staining on cytospins. Purity of the cell fractions was confirmed with immunohistochemical staining with ED-1 and His-48 for monocytes and neutrophilic granulocytes, respectively. Both the PMN-and the MNC-fraction proved to be > 95% pure.
Fig. 2: Immunohistochemical demonstration of RCMV-infected RFL-6 fibroblasts, after cocultivation with leukocytes isolated with rats infected with cell-free RCMV. Infection of fibroblasts with RCMV was confirmed after staining with Mab 8. Staining of viral antigens is visible in the nucleus of infected cells surrounding a plaque. Magnification 100x.
After cocultivation of granulocyte and monocyte fractions with RCMVinfected fibroblasts and subsequent purification by transmigration, the presence of RCMV DNA in these leukocytes could be confirmed by PCR (Fig. 3) . Both monocyte and granulocyte fractions were RCMV-DNA positive. Already after the first round of amplification, RCMV-DNA was detected on gel. 
control (RCMV-infected fibroblasts). As a control, GAPDH DNA was amplified for every sample (B).
The presence of virus particles inside infected fibroblasts and PMNs and monocytes was confirmed using EM-microscopy ( Fig. 4-6) . Virus particles were detectable in the nucleus and cytoplasm of infected fibroblasts. Moreover, virus was observed in the cytoplasm of both PMNs and monocytes. In addition, virus appeared to be present in vesicles in infected PMNs and monocytes, possibly indicating phagocytosis. In the PMNs, virus particles were hardly detectable in the nucleus, possibly indicating the absence of a productive infection. However, in the nucleus of monocytes virus particles were observed. Therefore, it is possible that monocytes were productively infected with RCMV. 
Transmission of RCMV in vivo by infected PMNs and monocytes.
Intravenous injection of RCMV-infected PMNs or monocytes resulted in a systemic infection. Fig. 7 shows the virus titres in spleens and salivary glands at 4 weeks post infection as determined by a plaque assay. Rats 1-4 were injected with infected PMNs, whereas Rats 5-8 were injected with infected monocytes. Injection of 70,000 PMNs resulted in higher virus titres as compared to injection with 35,000 PMNs. Injection of 70,000 mononuclear cells resulted in similar virus titres as compared to injection with 150,000 cells. Histochemical evaluation of 4 µm sections of salivary glands revealed dense leukocyte infiltrates and high numbers of owl's eyes in the secretory tubules ( fig. 8 ). These owl's eyes are a characteristic feature of CMV infection. 
DISCUSSION
During active infections with HCMV, infected PMNs and monocytes can be detected in the circulation of the infected subject. It has been hypothesised that these cells function as a vehicle for HCMV in the dissemination process 9, 11, 12, 26, 27 . HCMV does not replicate productively in these leukocytes, but virus can be cultured from the cells in vitro, indicating that infectious virus must be present in these cells 10, 11 . In addition, electron microscopy studies have confirmed the presence of intact virions in neutrophilic PMNs 9, 14, 21 .
In this study, RCMV DNA was isolated from whole blood of rats that were i.p. infected with cell free virus, up to 60 days post infection. In addition, virus from isolated PMNs and monocytes could be cultured in vitro. These data suggest that rats have a viremia caused by RCMV, which is comparable to a clinical HCMV infection. Earlier studies with MCMV also indicated a similar viremia in mice during active MCMV infection, with up to 0.1% MCMV-infected cells 1, 25 . In our studies, using a plaque assay, it was established that approximately 3% of the PMNs were infected with RCMV. From HCMV it is known that the percentage of infected leukocytes is up to 5% 21 .
In addition, we showed that RCMV-infected PMNs and monocytes generated in vitro were able to disseminate RCMV in vivo. Using PCR and electron microscopy, the presence of virus in these leukocytes after cocultivation with infected fibroblasts could be confirmed. Both infected PMNs and monocytes were able to transfer RCMV to uninfected fibroblasts in vitro. These results are comparable to data, obtained with HCMV in vitro 9, 11, 12, 26, 27 6 . These virulence genes are dispensable for viral replication in vitro, but are beneficial for replication and dissemination in vivo. Recently, virally encoded chemokines and chemokine receptors have been described in HCMV and murine CMV 3, 8, 19, 22 . These virally encoded chemokines are thought to specifically attract monocytes and PMNs and therefore may play a role in the dissemination process. Based on these observations, and the data we have obtained on this leukocyte mediated dissemination of RCMV in vivo, we hypothesise that the dissemination of cytomegalovirus by leukocytes, as demonstrated in our model, does not only play an important role during primary infections, but also during reactivation of CMV. A schematic representation of this proposed dissemination process is shown in Fig. 9 . Due to immunosuppression, the virus reactivates from a site of latency, e.g. an endothelial cell. The virus may spread to cells in the proximity and infect underlying tissues as well (step 1). Virally encoded chemokines are then released from infected cells, in order to attract PMNs and monocytes. These leukocytes adhere to the infected cell and transfer of the virus occurs (step 2 and 3). After infection of the leukocytes, the cells are able to migrate through the circulation and contact uninfected endothelial cells, or other target cells. Again, virus transfer takes place, leading to infection of target cells (step 4 and 5). Subsequently neighbouring cells or underlying tissues can be infected (step 5 and 6). 
cell. The virus may spread to cells in the proximity and infect underlying tissues as well (step 1). Virally encoded chemokines are released from infected cells and attract PMNs and monocytes, which take up virus (step 2 and 3). These infected leukocytes migrate through the circulation and transfer virus to uninfected endothelial cells, or other target cells (step 4 and 5). Subsequently neighbouring cells or underlying tissues are infected (step 5 and 6).
In conclusion, our study has shown that leukocytes can play an important role in the dissemination of RCMV in vivo. Likely, HCMV disseminates in humans in a similar manner during reactivations or primary infection with this virus. Therefore, our model will be a powerful tool for further studies in the viral dissemination process and may even be used for the evaluation of new antiviral drugs that can interfere with this dissemination process and subsequent infection.
